Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
04/11/2007 | CN1944433A 3-ene-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid amino acid amide, its synthetic method and light power therapeutic medicine |
04/11/2007 | CN1944432A 3-(1-alkoxy ethyl)-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid, its synthetic method and light power therapeutic medicine |
04/10/2007 | US7202279 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
04/10/2007 | US7202266 PPAR active compounds |
04/10/2007 | US7202255 Substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same |
04/10/2007 | US7202253 Cycloalkyl inhibitors of potassium channel function |
04/10/2007 | US7202245 Substituted 4-amino[1,2,4]triazolo[4,3-a] quinoxalines |
04/10/2007 | US7202243 Substituted imidazotriazines |
04/10/2007 | US7202240 Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a][1,4] benzodiazepines |
04/10/2007 | US7202239 Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists |
04/10/2007 | US7202238 Diazabicyclo alkane derivatives with NK1 antagonistic activity |
04/10/2007 | US7202224 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
04/10/2007 | CA2364199C Novel bicyclic derivatives of aminopyrazinone, process for their preparation and pharmaceutical compositions containing them |
04/10/2007 | CA2191746C [a]-annelated pyrrole derivatives and pharmaceutical use thereof |
04/05/2007 | WO2007038648A1 Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester |
04/05/2007 | WO2007038630A2 N-benzyl substituted pyridyl porphyrin compounds and methods of use thereof |
04/05/2007 | WO2007038314A2 Fused heterocyclic compounds useful as kinase modulators |
04/05/2007 | WO2007038284A1 7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]-2-(1-PROPYNYL)-7H-PYRAZOLO-[4,3-e]-[1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN-5 AMINE |
04/05/2007 | WO2007038215A1 Tetracyclic inhibitors of janus kinases |
04/05/2007 | WO2007038074A1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands |
04/05/2007 | WO2007037743A1 Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia |
04/05/2007 | WO2007037518A1 Mutilin derivative and pharmaceutical composition containing the same |
04/05/2007 | WO2007037039A1 Method of producing a metal phthalocyanine compound, and method of producing a phthalocyanine compound and an analogue thereof |
04/05/2007 | WO2007021575A3 Acetylenic piperazines as metabotropic glutamate receptor antagonists |
04/05/2007 | US20070078149 6-(2-Halophenyl)triazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds |
04/05/2007 | US20070078138 Analogs of dehydrophenylahistins and their therapeutic use |
04/05/2007 | US20070078136 Fused heterocyclic compounds useful as kinase modulators |
04/05/2007 | US20070078132 tyrosine kinase inhibitors such as 7H,19H-4,6-ethanediylidenepyrimido[4,5-b][13,1,4,6]benzoxatriazacyclopentadecine, 17-chloro-8,9,10,11,12,13-hexahydro, used for treating hyper proliferative disorders such as atherosclerosis, restenosis and cancer |
04/05/2007 | US20070078122 Indolobenzazepine HCV NS5B inhibitors |
04/05/2007 | US20070077195 "N and/or nalpha derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3 (co)3]+ by fac coordination" |
04/05/2007 | CA2624491A1 Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia |
04/05/2007 | CA2623369A1 Fused heterocyclic compounds useful as kinase modulators |
04/05/2007 | CA2623252A1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands |
04/05/2007 | CA2623047A1 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7h-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-c]-pyrimidin-5 amine |
04/05/2007 | CA2623034A1 Carboxyamine compounds and their use in the treatment of hdac dependent diseases |
04/05/2007 | CA2622701A1 Amino-aza-adamantane derivatives and methods of use |
04/05/2007 | CA2621261A1 Azepine inhibitors of janus kinases |
04/04/2007 | EP1768985A1 Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors |
04/04/2007 | EP1768983A2 Fused heterocyclic kinase inhibitors |
04/04/2007 | EP1768982A2 Pyrolo [2,3-d] pyrimidines that modulate ack1 and lck activity |
04/04/2007 | EP1576015A4 Preparation of metallotexaphyrins |
04/04/2007 | EP1377556B1 Pyrazole derivatives for treating hiv |
04/04/2007 | EP1227721B1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
04/04/2007 | EP1219609B1 Aromatic nitrogenous six-membered ring compounds |
04/04/2007 | EP1092435B1 Remedies for diabetes |
04/04/2007 | CN1942472A Reverse-turn mimetics and method relating thereto |
04/04/2007 | CN1942470A Akt活性抑制剂 Akt activity inhibitor |
04/04/2007 | CN1942190A Pyrrole derivatives as gonadotropin releasing hormone (GnRH) antagonists |
04/04/2007 | CN1939919A Low-toxic and broad-spectrum phthalocyanine bactericide, its production and use |
04/04/2007 | CN1308329C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
04/04/2007 | CN1308328C Novel process for the preparation of pyrazolopyrimidinones |
04/04/2007 | CN1308327C Imidazopyridine derivatives |
04/04/2007 | CN1308313C Fused azepine drivatives and their use as antidiuretic agents |
04/04/2007 | CN1308310C Nitrogenous aromatic ring compounds |
04/04/2007 | CN1308305C Method for synthesizing imide base substituted endo compound |
04/03/2007 | US7199248 Process |
04/03/2007 | US7199121 Protein tyrosine phosphatase inhibitor |
04/03/2007 | CA2296586C New 2,3-benzodiazepine derivatives |
04/03/2007 | CA2236269C Selective .beta.3 adrenergic agonists |
03/29/2007 | WO2007035841A1 Analogs of dehydrophenylahistins and their therapeutic use |
03/29/2007 | WO2007035542A1 2-HETEROARYL-PYRAZOLO-[4, 3-e]-1, 2, 4-TRIAZOLO-[1,5-c]-PYRIMIDINE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
03/29/2007 | WO2007034952A1 Luminescent vargula luciferin substrate and process for producing the same |
03/29/2007 | WO2007034278A2 Fused imidazole derivatives as c3a receptor antagonists |
03/29/2007 | WO2006130657A3 Stereoselective reduction process for the preparation of pyrrolotriazine compounds |
03/29/2007 | WO2006125101A3 Raf inhibitor compounds and methods of use thereof |
03/29/2007 | WO2006120478A3 Quinoline derivatives as neurokinin receptor antagonists |
03/29/2007 | WO2006094210A3 Tetrahydroquinoxalinone sirtuin modulators |
03/29/2007 | WO2006078676A3 Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
03/29/2007 | WO2006067419A3 Myrtaceous honey and the use thereof as immunomodulator |
03/29/2007 | WO2006024841A3 Benzamide compounds |
03/29/2007 | US20070073095 porphyrins or phthalocyanines; for chemical warfare, volatile organic compounds |
03/29/2007 | US20070073059 Method of producing azomethine dye compound |
03/29/2007 | US20070073053 Naphthalocyanine dye and method for producing the same |
03/29/2007 | US20070072888 Indol-3-yl-carbonyl-azaspiro derivatives |
03/29/2007 | US20070072882 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
03/29/2007 | US20070072881 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
03/29/2007 | US20070072880 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
03/29/2007 | US20070072879 Novel compounds as metabotropic glutamate receptor antagonists |
03/29/2007 | US20070072867 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-YL)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-c]-pyrimidin-5amine |
03/29/2007 | US20070072865 Bicyclic piperazine compound and use thereof |
03/29/2007 | US20070072864 fused tricyclic compounds useful as metabotropic glutamate receptor (mGluR) antagonists, particularly as selective metabotropic glutamate receptor 1 antagonists |
03/29/2007 | US20070072863 thieno [2,3-b: 5,4-c'] dipyridine derivatives, used as as selective metabotropic glutamate receptor 1 (mGluR1) antagonists, for the treatment of pain, headaches, anxiety, incontinence and neurodegenerative diseases such as Alzheimer's disease |
03/29/2007 | US20070072851 Pyrazolopyridine and pyrazolopyrimidine compounds |
03/29/2007 | US20070072849 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods |
03/29/2007 | US20070072846 Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto |
03/29/2007 | US20070072844 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
03/29/2007 | US20070072841 Therapeutic compounds |
03/29/2007 | US20070072838 High-purity texaphyrin metal complexes |
03/29/2007 | US20070072825 Erectile dysfunction, urinary incontinence, lung disease, hyperoxia, neurodegenerative disease, liver disease, myocardial damage during cardioplegia, an inflammatory condition, a reperfusion injury, an ischemic condition, a cardiovascular disease, diabetes, cancer |
03/29/2007 | US20070072812 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones |
03/29/2007 | US20070072792 Macrocyclic lactams and pharmaceutical use thereof |
03/29/2007 | DE102005017326A1 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories |
03/29/2007 | DE10116303B4 Vefahren zur Herstellung N-überbrückter Heterobicyclen Vefahren for preparing N-bridged heterobicycles |
03/29/2007 | CA2622741A1 2-heteroaryl-pyrazolo-[4, 3-e]-1, 2, 4-triazolo-[1,5-c]-pyrimidine as adenosine a2a receptor antagonists |
03/29/2007 | CA2619068A1 Imidazole compounds for the treatment of neurological disorders |
03/28/2007 | EP1767525A1 Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists |
03/28/2007 | EP1765827A2 A method for preparing pyrrolotriazine compounds |
03/28/2007 | EP1765826A2 Novel antiviral macrocycle derivatives and metal complexes, incorporating bridged macrocycles |
03/28/2007 | EP1765825A1 Condensed triazoles and indazoles useful in treating citokines mediated diseases and other diseases |
03/28/2007 | EP1765824A1 Substituted 6-phenyl-7-amino-triazolopyrimidines, method for the production thereof, their use for controlling pathogenic fungi, and agents containing these compounds |